Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 13

Effect of background long-acting beta2-agonist therapy on the efficacy and safety of a novel, nebulized glycopyrrolate in subjects with moderate-to-very-severe COPD

Total article views   Abstract views HTML views PDF downloads Totals
2,548 Dovepress* 1,964 344+ 426 2,308
PubMed Central* 0 240 99 240
Totals 1,964 584 525 2,548
*Since 19 September 2018
+Since July 2016

View citations on PubMed Central and Google Scholar